the impact of omidubicel on access to allogeneic transplantation
Published 2 years ago • 180 plays • Length 3:38Download video MP4
Download video MP3
Similar videos
-
5:00
an update on omidubicel
-
3:58
omidubicel versus standard ucb transplantation
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
1:11
personalized risk assessment for transplantation in primary immunodeficiency disorders
-
14:44
the role of allosct in patients with hl who relapse after autosct and the impact of novel agents
-
26:46
webinar recording | technology advances in hematology testing | sparrc 2021 by srmc | mindray india
-
15:50
how to find jobs in australia as an international medical graduate
-
27:13
interoperability in healthcare it, ehrs, applications, onc
-
2:41
an overview of the latest advances in hematology
-
1:13
efficacy of transplantation in hl
-
3:23
patient characteristics and outcomes of allosct for bpdcn
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
3:07
the impact of blast enumeration & co-occurring myelodysplasia-related mutations in npm1-mutated aml
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
1:30
the use of pirtobrutinib in richter's transformation: data from the bruin trial
-
1:19
the impact trials network
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
2:26
assessing the impact of momelotinib on transfusion burden in mf: analysis of simplify-1 & momentum
-
2:04
state-of-the-art treatment for hr-mds
-
1:23
current status of allohsct in bp-mpns
-
7:25
ai in hematology: advances, challenges, and future applications